After concluding that because myeloma drugs keep people alive longer they cost too much to be cost-effective, ICER through it’s Midwest Comparative Effectiveness Public Advisory Council (Midwest CEPAC) is now looking at new drugs for treating people with non small lung cancer.
And ICER’s Steve Pearson wants you to know that he and his organization care about patients. ICER’s website has a video of Pearson speaking before the Midwest CEPAC meeting entitled: “Why we are here today” – Dr. Pearson underscores the moral vision of the Midwest CEPAC” (Yes, that’s the title.)
In proclaiming this moral vision Pearson said: “we really want to know from patients what outcomes matter most to them.”
He also claims that the quality adjusted life year does not mean a life is “less valuable if they have or disability. a gain is a gain wherever you are starting from. Sometimes there are conditions where we have a serious condition and the first possible treatment, that’s an important consideration.”
These are outright falsehoods that hide Pearson’s real moral vision.